1247858

Blair M. Brengle, M.D. — FEI 3018034336

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 29, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Indianapolis, IN (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
2272821 CFR 312.64(b)Safety Reports - Non-Serious Events
753021 CFR 312.62(b)Case history records- inadequate or inadequate